DAPT - Longer is better - Rebuttal.

26 August 2018 (14:54 - 14:59)

Organised by:

Video

Sign in for access options

About the speaker

Doctor Jacob Allan Udell

University of Toronto, Toronto (Canada)

9 More presentations in this session

Presentation thumbnail

DAPT - Longer is better

Doctor J. Udell (Toronto, CA)

Presentation thumbnail

DAPT - Shorter is better

Professor M. Valgimigli (Lugano, CH)

Presentation thumbnail

DAPT - Shorter is better - Rebuttal.

Professor M. Valgimigli (Lugano, CH)

Presentation thumbnail

DAPT - Chairperson conclusion.

Doctor H. Mardikar (Nagpur, IN)

Presentation thumbnail

P2Y12 pretreatment in NSTE-ACS is needed

Professor P. Steg (Paris, FR)

Access the full session

Session thumbnail

Dual antiplatelet therapy and PCI - Important controversies

The Event

ESC Congress 2018

26 August 2018 14:54 CET

You may be interested in

Congress Presentation

Following an acute coronary syndrome, the default duration of dual antiplatelet therapy should be 12 months: con

30 August 2025

Congress Presentation

New insights into optimal duration of DAPT for high-risk "TWILIGHT-like" patients with diabetes mellitus undergoing PCI: a focus on diabetes mellitus as a high-risk patient group

28 August 2021

Congress Presentation

Thirty-days versus standard duration of dual antiplatelet treatment after percutaneous coronary interventions: a systematic review and meta-analysis

27 August 2022

Congress Presentation

Efficacy and safety of P2Y12 inhibitors plus aspirin versus aspirin alone in ischemic stroke or high-risk transient ischemic attack: a meta-analysis of randomized controlled trials

2 September 2024

ESC 365 is supported by

novartis

Explore sponsored resources

novo-nordisk

Explore sponsored resources

ESC 365 is supported by

novartis

Explore sponsored resources

novo-nordisk

Explore sponsored resources